Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.
Bioorg Med Chem
; 16(16): 7671-90, 2008 Aug 15.
Article
em En
| MEDLINE
| ID: mdl-18656367
ABSTRACT
Various iodo-acridone and acridine carboxamides have been prepared and evaluated as agents for targeted radionuclide and/or chemotherapy for melanoma, due to their structural similarity to benzamides which are known to possess specific affinity for melanin. Three of these carboxamides selected for their in vitro cytotoxic properties were radioiodinated with [(125)I]NaI at high specific activity. Biodistribution studies carried out in B16F0 murine melanoma tumour-bearing mice highlighted that acridone 8f and acridine 9d, presented high, long-lasting tumour concentrations together with an in vivo kinetic profile favourable to application in targeted radionuclide therapy.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Acridinas
/
Melanoma Experimental
/
Compostos Radiofarmacêuticos
/
Radioisótopos do Iodo
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2008
Tipo de documento:
Article